Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Peter Welford's Stock Ratings
Jefferies Analyst
Peter Welford is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/13/2025
Overall Average Return
8.84%
Smart Score
Overall Average Return Percentile
57th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/12/2024 | GSK | Buy Now | GSK | $41.61 | — | Peter Welford59% | — | Downgrade | Buy → Hold | Get Alert |
| 09/03/2024 | NVS | Buy Now | Novartis | $119.45 | — | Peter Welford59% | — | Downgrade | Buy → Hold | Get Alert |
| 07/02/2024 | NVS | Buy Now | Novartis | $119.45 | 2.55% | Peter Welford59% | $121 → $122.5 | Maintains | Buy | Get Alert |
| 07/02/2024 | GSK | Buy Now | GSK | $41.61 | 27.37% | Peter Welford59% | $52.5 → $53 | Maintains | Buy | Get Alert |
| 01/03/2024 | AZN | Buy Now | AstraZeneca | $74.42 | — | Peter Welford59% | — | Downgrade | Buy → Hold | Get Alert |
| 01/03/2024 | GSK | Buy Now | GSK | $41.61 | 15.36% | Peter Welford59% | $38.5 → $48 | Upgrade | Hold → Buy | Get Alert |
| 09/25/2023 | AZN | Buy Now | AstraZeneca | $74.42 | 7.5% | Peter Welford59% | $66.5 → $80 | Upgrade | Hold → Buy | Get Alert |
| 01/23/2023 | GLPG | Buy Now | Galapagos | $28.76 | 64.12% | Peter Welford59% | $49 → $47.2 | Upgrade | Underperform → Hold | Get Alert |
| 12/07/2021 | AZN | Buy Now | AstraZeneca | $74.42 | — | Peter Welford59% | — | Downgrade | Buy → Hold | Get Alert |
| 09/16/2021 | GMAB | Buy Now | Genmab | $22.82 | — | Peter Welford59% | — | Downgrade | Buy → Hold | Get Alert |
| 05/25/2021 | VACC | Buy Now | Vaccitech | — | — | Peter Welford59% | → $28 | Initiates | → Buy | Get Alert |
| 03/16/2021 | AZN | Buy Now | AstraZeneca | $74.42 | — | Peter Welford59% | — | Upgrade | Hold → Buy | Get Alert |
| 08/25/2020 | GLPG | Buy Now | Galapagos | $28.76 | — | Peter Welford59% | — | Downgrade | Buy → Hold | Get Alert |
| 07/29/2019 | GLPG | Buy Now | Galapagos | $28.76 | — | Peter Welford59% | — | Downgrade | Buy → Hold | Get Alert |
| 02/01/2019 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | — | Downgrade | Buy → Hold | Get Alert |
| 07/11/2017 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | → $160 | Assumes | → Buy | Get Alert |
| 10/05/2016 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | $137 → $134 | Maintains | Buy | Get Alert |
| 10/15/2015 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | $140 → $137 | Maintains | Buy | Get Alert |
| 09/09/2015 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | → $140 | Initiates | → Buy | Get Alert |
| 02/02/2015 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | $98 → $140 | Maintains | Buy | Get Alert |
| 04/11/2013 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | $114 → $140 | Maintains | Buy | Get Alert |
| 01/25/2013 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | $104 → $114 | Maintains | Buy | Get Alert |
| 01/08/2013 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | $94 → $104 | Maintains | Buy | Get Alert |
| 11/12/2012 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | $91 → $94 | Maintains | Buy | Get Alert |
| 10/03/2012 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | $81 → $91 | Maintains | Buy | Get Alert |
| 08/21/2012 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | $80 → $81 | Maintains | Buy | Get Alert |
| 07/27/2012 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | $75 → $80 | Maintains | Buy | Get Alert |
| 06/22/2012 | CELG | Buy Now | Celgene | — | — | Peter Welford59% | $85 → $75 | Maintains | Buy | Get Alert |
